DEUTSCHE BANK AG\ - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 99 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$90,000
-21.1%
72,425
+1.9%
0.00%
Q4 2021$114,000
-72.6%
71,047
-44.4%
0.00%
Q3 2021$416,000
-5.2%
127,749
+83.9%
0.00%
Q2 2021$439,000
+3890.9%
69,454
+1473.5%
0.00%
Q3 2020$11,000
+10.0%
4,414
-31.0%
0.00%
Q4 2019$10,0006,394
+2031.3%
0.00%
Q2 2019$0300
+4185.7%
0.00%
Q3 2018$0
-100.0%
7
-99.7%
0.00%
Q2 2018$4,0002,2070.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 362,072$453,0000.07%
GSA CAPITAL PARTNERS LLP 66,223$83,0000.01%
Aquatic Capital Management LLC 4,400$6,0000.01%
D. E. Shaw & Co., Inc. 3,863,135$4,829,0000.01%
Spire Wealth Management 94,000$118,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 111,898$140,0000.00%
Renaissance Technologies 2,100,492$2,626,0000.00%
ALPS ADVISORS INC 130,141$163,0000.00%
Cutler Group LLC / CA 21,400$30,0000.00%
TWO SIGMA ADVISERS, LP 681,600$852,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders